Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and … D Petras, L Sanz, A Segura, M Herrera, M Villalta, D Solano, M Vargas, ... Journal of proteome research 10 (3), 1266-1280, 2011 | 235 | 2011 |
Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms G León, M Herrera, Á Segura, M Villalta, M Vargas, JM Gutiérrez Toxicon 76, 63-76, 2013 | 169 | 2013 |
Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: State-of-the-art and challenges ahead JM Gutiérrez, G Solano, D Pla, M Herrera, Á Segura, M Vargas, M Villalta, ... Toxins 9 (5), 163, 2017 | 158 | 2017 |
Current technology for the industrial manufacture of snake antivenoms G León, M Vargas, Á Segura, M Herrera, M Villalta, A Sánchez, G Solano, ... Toxicon 151, 63-73, 2018 | 91 | 2018 |
Pathogenesis of dermonecrosis induced by venom of the spitting cobra, Naja nigricollis: An experimental study in mice M Rivel, D Solano, M Herrera, M Vargas, M Villalta, Á Segura, AS Arias, ... Toxicon 119, 171-179, 2016 | 84 | 2016 |
Assessing the preclinical efficacy of antivenoms: From the lethality neutralization assay to antivenomics JM Gutiérrez, G Solano, D Pla, M Herrera, Á Segura, M Villalta, M Vargas, ... Toxicon 69, 168-179, 2013 | 78 | 2013 |
Snake venomics and antivenomics of Protobothrops mucrosquamatus and Viridovipera stejnegeri from Taiwan: keys to understand the variable immune response in horses M Villalta, D Pla, SL Yang, L Sanz, A Segura, M Vargas, PY Chen, ... Journal of proteomics 75 (18), 5628-5645, 2012 | 75 | 2012 |
Assessment of snake antivenom purity by comparing physicochemical and immunochemical methods Á Segura, M Herrera, M Villalta, M Vargas, JM Gutiérrez, G León Biologicals 41 (2), 93-97, 2013 | 74 | 2013 |
Comparative proteomic analysis of the venom of the taipan snake, Oxyuranus scutellatus, from Papua New Guinea and Australia: Role of neurotoxic and procoagulant effects in … M Herrera, J Fernández, M Vargas, M Villalta, Á Segura, G León, ... Journal of proteomics 75 (7), 2128-2140, 2012 | 72 | 2012 |
Preclinical Evaluation of Caprylic Acid-Fractionated IgG Antivenom for the Treatment of Taipan (Oxyuranus scutellatus) Envenoming in Papua New Guinea M Vargas, A Segura, M Herrera, M Villalta, R Estrada, M Cerdas, O Paiva, ... PLoS neglected tropical diseases 5 (5), e1144, 2011 | 62 | 2011 |
Proteomic, toxicological and immunogenic characterization of Mexican west-coast rattlesnake (Crotalus basiliscus) venom and its immunological relatedness with the venom of … Á Segura, M Herrera, FR Mares, C Jaime, A Sánchez, M Vargas, ... Journal of proteomics 158, 62-72, 2017 | 53 | 2017 |
Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature A Segura, M Herrera, E Gonzalez, M Vargas, G Solano, JM Gutiérrez, ... Toxicon 53 (6), 609-615, 2009 | 44 | 2009 |
Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries M El-Ekiaby, M Vargas, M Sayed, G Gorgy, H Goubran, M Radosevic, ... PLoS neglected tropical diseases 9 (2), e0003501, 2015 | 41 | 2015 |
Development of a new polyspecific antivenom for snakebite envenoming in Sri Lanka: Analysis of its preclinical efficacy as compared to a currently available antivenom M Villalta, A Sánchez, M Herrera, M Vargas, Á Segura, M Cerdas, ... Toxicon 122, 152-159, 2016 | 40 | 2016 |
Venom of Bothrops asper from Mexico and Costa Rica: Intraspecific variation and cross-neutralization by antivenoms Á Segura, M Herrera, M Villalta, M Vargas, A Uscanga-Reynell, ... Toxicon 59 (1), 158-162, 2012 | 39 | 2012 |
In Vitro Tests for Assessing the Neutralizing Ability of Snake Antivenoms: Toward the 3Rs Principles JM Gutiérrez, M Vargas, Á Segura, M Herrera, M Villalta, G Solano, ... Frontiers in Immunology 11, 617429, 2021 | 34 | 2021 |
Purification of IgG and albumin from human plasma by aqueous two phase system fractionation M Vargas, Á Segura, M Herrera, M Villalta, Y Angulo, JM Gutiérrez, ... Biotechnology progress 28 (4), 1005-1011, 2012 | 32 | 2012 |
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19 G Leon, M Herrera, M Vargas, M Arguedas, A Sanchez, A Segura, ... Scientific reports 11 (1), 9825, 2021 | 28 | 2021 |
Freeze-dried snake antivenoms formulated with sorbitol, sucrose or mannitol: Comparison of their stability in an accelerated test M Herrera, V Tattini Jr, RNM Pitombo, JM Gutiérrez, C Borgognoni, ... Toxicon 90, 56-63, 2014 | 28 | 2014 |
Proteomic and toxinological characterization of the venom of the South African Ringhals cobra Hemachatus haemachatus A Sánchez, M Herrera, M Villalta, D Solano, Á Segura, B Lomonte, ... Journal of proteomics 181, 104-117, 2018 | 27 | 2018 |